A. Introduction
In this brief review we will discuss some re cent trends in work on regulatory mechanisms involved in the selective expression of differentiated markers in human B-ceIllines as weIl as the types of controls involved in the expression and function of Epstein-Barrvirus (EBV) associated markers in human cells. A problem of special interest in this connection is the relation of the expression of EBV functions to the expression of "transformation".
In man EBV is a lymphotropic herpesvirus (Epstein and Achong 1979) . Its main target is the human B-Iymphocyte (Jondal and Klein 1973), though EBV may be able to infect other cell types, provided that the membrane barrier is surpassed. EBV is known to be the causative agent of infectious mononucleosis (IM) (He nie and Henle 1979) and is associated with the two completely different human malignancies: African Burkitt's lymphoma (BL), i.e. malignant proliferation of B-cells (Fialkow et al. 1970) , and nasopharyngeal carcinoma (NPC), i.e. malignant proliferation of epithelial carcinoma cells . In both of these cases, the presence of the EBV genome is demonstrated by the presence of EBV DNA as well as by the presence of EBV -specific antigens. The case of NPC in itself indicates that cell types other than B-Iymphocytes under the right conditions can be infected byEBV. In addition to in vitro transformed lymphoblastoid cell lines (LCL), a wide variety of B -celllines of BL origin are available; so far it has not been possible to grow celliines from NPC tumors.
B. Lymphoid Cell Lines
Infection of B-Iymphocytes by EBV regularly leads to transformation ("immortalization") into LCL (Pope 1979) . Normally, B-Iymphocytes are transitory cells located within a chain of differentiation which proceeds from primitive stern cells toward mature, immunoglobulinsecreting end cells (i.e., plasma cells). EBV cannot infect either stern cells or plasma cells. Infection of B-Iymphocytes is sharply restricted to surface immunoglobulin and compleme nt (C3) receptor positive B-cells (Einhorn et al. 1978) . The EBV receptor is closely related to, and perhaps identical with, the complement (C3) receptor on B-cells (Jondal et al. 1976 ). The cell lines of BL origin in contrast to uncloned LCL cells appear to represent clones of proliferating neoplastic cells (Van Furth et· al. 1972; Bechet et al. 1974) . In contrast to myeloma celllines which represent the plasma cell type of differentiation and secrete immunoglobulin at a high rate (Matsuoka et a1. 1968) , BL-derived celliines correspond to an intermediate step in B-cell differentiation and synthesize immunoglobulins, usually IgM, which are almost exclusively destined for plasma membrane integration (Klein et al. 1970; Eskeland and Klein 1971) . LCL cells appear to represent a step which is intermediate between BL and myeloma cells, and immunoglobulin secretion is observed (Nilsson and Ponten 1975) . Rosetting B-cells with antigen coated erythrocytes prior to in vitro EBV transformation has permitted the establishment of LCL clones that produce human monoc1onal antihapten antibodies Kozbor et al. 1979) , anti-Rh (D) antibodies (Koskimies 1980), anti-strep-tococcal antibodies , and Rheumatoid Factor (IgM anti-IgG) (Steinitz et al., to be published) .
In addition to immunoglobulin expression, other B-cell markers are useful in characterizing the state of differentiation of lymphoid celliines. The Fe' complement (C3), and EBV receptors are fully expressed by BL cells, but their expression is decreased in LCL lines and absent on myeloma lines. Ia-like antigens are expressed by both BL and LCL cells, but their expression is decreased on myeloma cells. Insulin receptors are not expressed by typical BL cells but are expressed by LCL cells. These patterns of expression are related to the expression of these markers during the normal B-celllineage (Nilsson 1978).
C. Chromosome studies on LCL and BL CellLines
All newly established LCL lines have been found to be normal diploid or to reflect the karyotype of the patient from which they were established. The lines studied have included LCL lines established spontaneously from blood of patients with acute IM (Jarvis et al. 1974 ) and leukemia (Hellriegel et al. 1977) as weIl as lines established from cord and adult peripheral blood by me ans of exogenous EBV or by cocultivation with X-irradiated EBVproducing cells (J arvis et al. 1974; Hellriegel et al. 1977; Zech et al. 1976) . In lines cultivated for longer times secondary changes towards aneuploidy are very often seen and gains appear to be more frequent than losses of chromosomes. Chromosome gains are not randam, since trisomy is often found for chromosomes 3, 7, 8,9, and 12 ; the trisomy 7 is particularly interesting, since it is found in both BL and non-BL lymphoma lines (Zech et al. 1976; Steel et al. 1977) . Freshlyestablished LCL lines from normal donors usually clone at low frequency ( <2 %) and are nontumorigenic in nude mice, while some long-term cultivated lines were found to be tumorigenic in nude mice (Nilsson et al. 1977) . Most BL cell lines are aneuploid. The chromosome 14 marker, first detected by Manolov and Manolova (1972) in BL biopsy cells and BL celllines, has subsequently been identified in all BL cell lines examined with only a few exceptions. The chromosome 14 marker was originally described as an extra band located at the end of the long arm of one chromosome 14 (14q +). Zech et al. (1976) were able to identify the translocation of a segment from the end of one of the long arms of chromosome 8 to chromosome 14 [t(8;14)(q24;q32) .]. Similar chromosome abnormalities have been identified in other malignant lymphomas, but here the donor chromosomes were often variable. The specificity of the 14q + anomaly in BL has recently been questioned by Van Den Berghe et al. (1979) , who found a t(2 ;8)(pI2 ;q23) in a child with typical European BL, which points to the possibility that chromosome 8 (8q -) may be more specific for the disease than the 14q + .
Other chromosomal changes are often found in BL lines, such as trisomy 7 (Zech et al. 1976; Steel et al. 1977) . Since this change is also found in long-term cultured LCL cells and a certain preferential retention of chromosome 7 has also been observed in hybrid cells where human chromosomes are lost, it is a possibility that these changes are selected for in tissue culture. In two BL lines (DAUDI and NA-MALW A) a region in the long arm of one chromosome 15 was lost or translocated (Zech et al. 1976; . The deletion of this region (qI4-q21) was associated with the complete absence of ~-microglobulin (DAUDI) or a reduction (NAMALWA) . The gene for ~-micro globulin is located on chromosome 15 (Goodfellow et al. 1975) , and the extent of this interstitial deletion agrees well with more re cent regional mapping data (Oliver et al. 1978) . The karyotype of DAUDI cells is interesting also in the sense that it shows no further changes than the del(15) chromosome and the t(8;14) marker from the normal diploid karyotype in contrast to other commonly used BL cell lines. In various mutant sublines of DAUDI we have found identical karyotypes with so far only one exception (DAUDI-ouabf-TGf) which in addition showed trisomy 7 as weH as a 3q + marker. The picture for other commonly used BL sublines (e.g., RAJI and NAMALWA) is much more complicated.
The EBV-negative lymphoma line BJAB, though reported to be derived from an African BL patient (Menezes et al. 1975) , clearly lacks the 14q + marker; in this ca se the original diagnosis may be doubtful, however. The EBV-negative American BL line RAMOS ) has a 14q + marker ). The BJAB cellline in contrast to RAMOS is nontumorigenic in nude mice and also clones with low efficiency in agarose. Interestingly, the relatively nontransformed phenotype of BJAB dominates in hybrids with the highly transformed RAJI line, since these are low tumorigenie and clone with low efficiency in aga rose (I. Ernberg, Re. Giovanella, J. Zeuthen, unpublished). The two different EBV -negative lines have been converted to EBV -positive sublines by infection with two different strains of EBV (B95-8 and P3HR-1) (Klein et al. 197 6a; Fresen and Zur Hausen 1976; Steini tz and Klein 1975) . The converted sublines did not differ from their parents with respect to surface immunoglobulin or Fe receptors, but a significant increase in both EBV and complement (C3) receptors was observed (Klein et al. 1976a ). All the EBV converted sublines have shown an increasingly transformed phenotype as evidenced by increased resistance to saturation, decreased serum dependence, decreased capping of surface markers, increased lectin agglutinability, and an increased ability to activate the alternative complement pathway Yefenof and Klein 1976; McConnell et al. 1978; Montagnier and Gruest 1979) . Analyses ofthe karyotypes of the EBV converted lines as compared to their EBV negative parents do not indieate any consistent chromosomal changes whieh could explain their changed growth characteristies.
The precise role of chromosome 14 anomalies in the development of lymphomas in unknown, but it has been suggested that the re arrangement of the distal part of the long arm somehow can be advantageous for the lymphoid cells during the suggested stepwise development of an autonomous BL clone (Zech et al. 1976 ). This suggestion is supported by the finding of re arrangements of chromosome 14 in ataxia telangiectasia (AT), a hereditary disease associated with increased chromosome breakage as weH as lymphoid neoplasia (McCaw et al. 1975) . Most AT patients have clones marked by a translocation involving chromosome 14. The breaks observed in chromosome 14 have always been in the long arm at the qll-q12 region, and the other chromosomes involved in the translocations observed have been chromosomes 7,8, 14, and X. Chromosome 14 re arrangements are found in varying proportions (2 %-5 %) in lymphocytes, and breakage and chromosome 14 rearrangements are highly reduced in EBV -transformed LCL lines . LCL lines derived from AT patients clone at slightly increased frequencies compared to lines from normal individuals or AT carriers. By successive cloning of an AT -derived LCL lines, subclones cloning at high efficiency whieh are also tumorigenie in nude miee were isolated, but we have not been able to correlate this secondary change with specific chromosomal changes (I. Ernberg et al. , unpublished work). It is, however, possible that in vivo selected tumorigenie subclones could show specific canges.
The individuality of the different BL lines with respect to chromosome markers have proven of great value for our work on the characterization of different hybrid cell lines obtained by fusion of BL cells. The regular presence of these markers in the parental ceHs and their hybrids has made it possible to identify hybrid cells by detailed chromosome analysis. An example of the identifieation of a typieal hybrid ceH (in this case DAUDII P3HR-l) (Ber et al. 1978 ) is indicated in Fig.  1 .
D. Studies with Hybrid Cells
In hybrids between the two BL derived cell lines RAJI and NAMALW A , which express either small amounts of IgM x (RAJI) or large amounts of IgMA(NA-MALW A) it was possible to quantitate the amounts of the two different types of light chains produced by the hybrid by means of radioimmunoassay. In spite of some variability between various clones tested, it appears that the hybrids expressed the same level of x and A light chains as expressed by the parents individually. We can conclude that the exclusion of one of the light chains (A or x) in BL cells probably does not operate through soluble repressing factors or activating substances, since the production of x and A proceeded simultaneously and at fixed levels in the hybrid clones. The event of allelic exclusion has presumably already taken place by the programming of the genome (i.e., the V-Cjoining step) and has taken place on only one of the two homologous chromosomes for each immunoglobulin gene family (Bernard et al. 1978) . In subsequent studies the analysis of immunoglobulin gene expression was extended to .... For discussion see text P3HR-l (Klein et al. 1980 ) showed a complete suppression of EBV receptors, and a DA UD 11 K562 hybrid showed a complete suppression of surface IgM in addition to other lymphoid markers (Zeuthen et al. , to be published). Both of these two hybrid combinations had similarly high levels of heme as the K562 parent and were inducible for hemoglobin synthesis by addition of hemin. An example of the induction of hemoglobin-positive cells stained by benzidine is illustrated in Fig. 3 coexpressed in cell hybrids. This has been the case for isoenzyme markers, which in addition to our chromosomal characterization have been a useful tool in the identification of hybrid cells. One curious deficiency of BL cells is a loss of soluble malic enzyme (ME s ), though this enzyme is expressed by other cell types (Povey et al., to be published). ME s is re-expressed in hybrids of BL cells with mouse fibroblasts and in the two hybrids with K562. The lll.A specificities of the parental cells are coexpressed in hybrids. A special case here is the hybrids with DAUDI cells (f32-microglobulin and HlA negative), where we found expression of completely new HlA specificities (AlO,B38,BI7) (Klein et al. 1977b; Fellous et al. 1977) . We have interpreted this observation to indicate genetic complementation of the f32-microglobulin deficiency of DAUDI to bring out its hidden HlA specificities in the form of new f32-microglobulin-HlA dimer molecules on the cell membrane. The K562 line shows a similar lack of surface expressed HlA and f32-microglobulin to DAUDI, though its intracellular content of ß2-microglobulin is normal . This membrane defect is partially dominant in the P3HR-lIK562 hybrid , since only one P3HR-l derived specificity (HlA-A3) could be detected in low amounts on the hybrid. In spite of this, complementation of the two kinds of defects were observed in the DAUDIIK562 hybrid by the expression of low amounts of HlA-B17, one of the "hidden" specificities characteristic of DAUDI cells (Zeuthen et al., to be published). A direct analysis of solubilized membrane proteins from this hybrid by crossed radioimmunoelectrophoresis (Plesner 1978) confirmed the presence of f32-microglobulin-HlA dimer molecules in low concentration.
E. Expression of EBV, the EBNA Antigen, and Transformation
Multiple copies of EBV viral genomes are present in EBV -carrying eells of both BL and LCL origin ). These cells invariably contain the EBV -determined nuclear antigen EBNA (Reedman and Klein 1973) . While EBNA is always expressed if the EBV genome is present, the early antigens (EA) and viral capsid antigens (VCA) are only expressed during the lytie eyde (Ernberg and Klein 1979). The EBV-carrying cell lines can be dassified into three cathegories: nonproducers (EBNA +, EA -, VCA -), abortive producers (EBNA +, EA +, VCA -), and finally producers (EBNA+, EA+, VCA+). The number of cells entering the lytic cyde can be amplified by inducers (IUdR, Na-butyrate, TP A) whose only common denominator is a known effect on differentiation in a variety of cell systems. Abortive producers such as RAJI switch on EA production in a small proportion of cells, but these do not proceed further to viral DNA synthesis and VCA production (Gergely et al. 1971) . The block in the abortive producer celliines could either be due to viral defectiveness or to negative cellular controls. The latter is more likely, since we have recently found that hybridization of RAJI with BJAB lifts the block to viral DNA replication and subsequent VCA production.
Other combinations in cell hybrids have given us further information with respect to the types of controls involved. With certain minor variations, the picture is consistent: When producer BL lines are fused with nonproducers, producer status tends to dominate over nonproducer status and inducibility over noninducibility (Ber et al. 1978; Nyormoi et al. 1973; Klein et al. 1976b Klein et al. , 1977b . This suggests that the controls appear to be of a positive nature. The results on the RAJI/BJAB hybrid and the observation that inducers used interfere with differentiation, while standard mutagenic or carcinogenic agents are noninducers (Zur Hausen et al. 1979) , strongly suggests that the controls are cellular rather than viral.
It is of interest that EBV production and inducibility in many cases parallel the behavior of other B-cell markers in cell hybrids. In the cases where BL cells were hybridized with fibroblasts, virus production and inducibility were switched off in spite of the continued presence of EBV-DNA in multiple genome copies per cell and uninfluenced expression of EBNA (Klein et al. 1974; Glaser et al. 1977 ). In the P3HR-l/K562 hybrid a similarcomplete block against EA and VCA inducibility was observed using the three inducers IUdR, Na-butyrate and TPA . The DAUDI/K562 hybrid (Zeuthen et al., to be published), however, was inducible, probably due to a higher number of EBV copies.
An exception to the rule of extinction of EBV inducibility in hybrids of BL cells with other lineages are hybrids with human carcinoma cells (Glaser and Rapp 1972; Glaser and Nonoyama 1973; Tanaka et al. 1977; Baron and Strominger 1978) , were the hybrids were completely permissive. This observation might be of some relevance to NPC, since epithelial carcinoma cells might be more compatible with EBV production than other human cells of non-B-cell origin.
Like the T antigens of the small DNA viruses, EBNA is a DNA binding protein (Lenoir et al. 1976; Luka et al. 1977 Luka et al. , 1978 , to be published). Purified EBNA antigen has a molecular weight of ,,-,180,000 daltons and consists of two major components of 48,000 and 53,000 daltons (Luka et al., to be published). While the 48K component is probably virus coded, the 53K component is also found in EBV -negative lymphoma lines, but not in T -cell derived celllines. It is, therefore, possible that the 53K protein is a nudear protein characteristic of malignant B-cells. A similar 53K component has been found in SV40 T antigen (McCormick and Harlow 1980) , suggesting a further analogy between EBV and the much smaller papovaviruses. In recent experiments we have used fusion of EBNA loaded erythrocyte ghosts with quiescent cells to "microinject" (Klein et al. 1980, Zeuthen, unpublished work) . In these experiments a stimulation of cellular DNA synthesis was observed to occur after microinjection (Fig. 4) . In experiments with the isolated 48K and 53K components, the 53K component appears to have this activity. These observations are similar to the stimulation of DNA synthesis in quiescent cells after microinjection of the SV40 T antigen (Tjian et al. 1978) .
A quantitative relation between SV 40 T antigen levels and virallate gene expression was recently described (Graessmann et al. 1978 ): SV40-infected cells with levels of T antigen above a certain treshold value expressed late viral genes. An interpretation of this observation is that an excess of T antigen is required to saturate binding sites on cellular DNA and in addition provide sufficient molecules to initiate DNA replication (and late gene expression). A similar mechanism could perhaps control the induction of viral DNA synthesis and VCA production in BL cells. Measurements by immunofluorimetry of EBNA in induced cultures of RAH, DAUDI, and P3HR-1 cells show that EBNA immunofluorescence after induction is doubled after induction in the producer lines (DAUDI and P3HR-1), but in fact reduced for the abortive producer RAH line (Zeuthen and Ernberg, unpublished work). These observations could indicate a role of EBNA in the control of viral DNA synthesis and could possibly indicate a defect in RAH cells responsible for its abortive producer status. An example of these measurements is shown in Fig. 5 . Microinjection by capillaries has been used in attempts to infect cells that lack EBV receptors with EBV-DNA or EBV viral particles. In experiments where fibroblasts were injected with P3HR-1 EBV-DNA, cells were induced to produce EA (Graessmann et al. 1980) . Using a similar technique, we injected human amnion epithelial cells with a 100 X concentrated supernatant of B95-8 cells and found 50%-100% of the injected cells to become positive for EBNA (Zeuthen J, Rosenbaum S, S0rensen ET, unpublished) (Fig. 6 ). 
